Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV Medicine ◽  
2015 ◽  
Vol 16 ◽  
pp. 129-136 ◽  
Author(s):  
GV Matthews ◽  
J Neuhaus ◽  
S Bhagani ◽  
SH Mehta ◽  
E Vlahakis ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Antiretroviral Treatment ◽  
Hiv Positive ◽  
Treatment Start ◽  
Start Trial

Abstract P172: Association of Interleukin 6 With Hypertension in HIV Positive Participants in the Strategic Timing of Antiretroviral Treatment (START) Trial

Circulation ◽  
2019 ◽  
Vol 139 (Suppl_1) ◽  
Author(s):  
Lama Ghazi ◽  
Jason V Baker ◽  
Shweta Sharma ◽  
Mamta K Jain ◽  
Adrian Palfreeman ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Antiretroviral Treatment ◽  
Hiv Positive ◽  
Treatment Start ◽  
Start Trial

scholarly journals Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV Medicine ◽  
2015 ◽  
Vol 16 ◽  
pp. 10-13 ◽  
Author(s):  
N Geffen ◽  
P Aagaard ◽  
GM Corbelli ◽  
M Meulbroek ◽  
D Peavy ◽  
...  
Keyword(s):  
Antiretroviral Treatment ◽  
Treatment Start ◽  
Start Trial

scholarly journals Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV Medicine ◽  
2015 ◽  
Vol 16 ◽  
pp. 46-54 ◽  
Author(s):  
EZ Soliman ◽  
S Sharma ◽  
K Arastéh ◽  
D Wohl ◽  
A Achhra ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Antiretroviral Treatment ◽  
Treatment Start ◽  
Start Trial

scholarly journals Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV Medicine ◽  
2015 ◽  
Vol 16 ◽  
pp. 77-87 ◽  
Author(s):  
JD Baxter ◽  
D Dunn ◽  
E White ◽  
S Sharma ◽  
AM Geretti ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Antiretroviral Treatment ◽  
Transmitted Drug Resistance ◽  
Treatment Start ◽  
Start Trial ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document